XPER Research Acquires Medical and Regulatory Writing Company Lorentis
The acquisition of Lorentis reinforces XPER’s commitment to become the go-to boutique CRO for the MedTech and IVD sector across the globe.
Menu
The acquisition of Lorentis reinforces XPER’s commitment to become the go-to boutique CRO for the MedTech and IVD sector across the globe.
XPER Research welcomes three new managing partners, strengthening its leadership and reinforcing its position as a leading boutique MedTech CRO.
